Jean-Charles Soria to Carcinoma
This is a "connection" page, showing publications Jean-Charles Soria has written about Carcinoma.
Connection Strength
0.526
-
Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1-Positive Endometrial Cancer: Results From the KEYNOTE-028 Study. J Clin Oncol. 2017 Aug 01; 35(22):2535-2541.
Score: 0.526